PlainRecalls
FDA Drug Moderate Class II Terminated

Diclofenac Sodium and Misoprostol Delayed Release Tablets 75 mg/0.2 mg, 60-count bottle, Rx Only, Manufactured by: Cipla Ltd., India; For: EAGLE PHARMACEUTICALS, INC., Woodcliff Lake, NJ 07677 USA, NDC 42367-111-06.

Reported: May 30, 2018 Initiated: April 20, 2018 #D-0826-2018

Product Description

Diclofenac Sodium and Misoprostol Delayed Release Tablets 75 mg/0.2 mg, 60-count bottle, Rx Only, Manufactured by: Cipla Ltd., India; For: EAGLE PHARMACEUTICALS, INC., Woodcliff Lake, NJ 07677 USA, NDC 42367-111-06.

Reason for Recall

Labeling: Label Mix-Up: bottle labeled as Diclofenac Sodium and Misoprostol 75 mg/0.2 mg contained Diclofenac Sodium and Misoprostol 50 mg/0.2 mg tablets.

Details

Recalling Firm
Exela Pharma Sciences LLC
Units Affected
5256 bottles
Distribution
Nationwide in the USA and Puerto Rico
Location
Lenoir, NC

Frequently Asked Questions

What product was recalled?
Diclofenac Sodium and Misoprostol Delayed Release Tablets 75 mg/0.2 mg, 60-count bottle, Rx Only, Manufactured by: Cipla Ltd., India; For: EAGLE PHARMACEUTICALS, INC., Woodcliff Lake, NJ 07677 USA, NDC 42367-111-06.. Recalled by Exela Pharma Sciences LLC. Units affected: 5256 bottles.
Why was this product recalled?
Labeling: Label Mix-Up: bottle labeled as Diclofenac Sodium and Misoprostol 75 mg/0.2 mg contained Diclofenac Sodium and Misoprostol 50 mg/0.2 mg tablets.
Which agency issued this recall?
This recall was issued by the FDA Drug on May 30, 2018. Severity: Moderate. Recall number: D-0826-2018.